Innate Pharma SA Vs. Cellectis SA Industry Stock Comparison

Sell

36

IPHYF
Innate Pharma SA

Last Price:

2.20

Seasonality Move:

-9.08%

Buy

81

CLLS
Cellectis SA

Last Price:

3.01

Seasonality Move:

-2.97%

Sell

36

Innate Pharma SA (IPHYF) is a Sell

Is Innate Pharma SA a Buy, Sell or Hold?

The current Innate Pharma SA [IPHYF] share price is $2.20. The Score for IPHYF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
IPHYF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

81

Cellectis SA (CLLS) is a Buy

Is Cellectis SA a Buy, Sell or Hold?

The current Cellectis SA [CLLS] share price is $3.06. The Score for CLLS is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
CLLS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.

IPHYF Stock Price Chart

What is Innate Pharma SA's stock price today?

The Innate Pharma SA share price today is $2.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHYF is experiencing slight buying pressure.

CLLS Stock Price Chart

What is Cellectis SA's stock price today?

The Cellectis SA share price today is $3.06
The current trend is moderately bullish and CLLS is experiencing slight buying pressure.

IPHYF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.12	Sell
Relative Strength Index (14 RSI):	19.31	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.26 - 2.7)	Sell
Bollinger Bands (100):	(2.45 - 2.87)	Sell

CLLS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.13	Buy
Relative Strength Index (14 RSI):	58.29	Buy
Chaikin Money Flow:	4259	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(2.49 - 3.05)	Buy
Bollinger Bands (100):	(2.54 - 3.06)	Buy

IPHYF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	2.19	Buy
20-day SMA:	2.44	Sell
50-day SMA:	2.49	Sell
200-day SMA:	2.68	Sell
8-day EMA:	2.24	Sell
20-day EMA:	2.37	Sell
50-day EMA:	2.5	Sell
200-day EMA:	2.67	Sell

CLLS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	3.12	Sell
20-day SMA:	2.82	Buy
50-day SMA:	2.68	Buy
200-day SMA:	2.44	Buy
8-day EMA:	3.03	Buy
20-day EMA:	2.9	Buy
50-day EMA:	2.78	Buy
200-day EMA:	2.61	Buy

Innate Pharma SA Earnings Growth & IPHYF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cellectis SA Earnings Growth & CLLS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.32 per share, and a decrease next year of $1.32 per share.

Innate Pharma SA Technical Analysis

	May 2	May 3	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15
	May
	02	03	06	07	08	09	10	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cellectis SA Technical Analysis

	May 2	May 3	May 6	May 7	May 8	May 9	May 10	May 13	May 14	May 15
	May
	02	03	06	07	08	09	10	13	14	15
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):